Beginning Oct. 1, the US will impose a 100% tariff on branded and patented pharmaceutical imports unless manufacturers are ...

Capturing insights from executives and industry experts on the biggest challenges shaping pharma today, from drug pricing pressures and access barriers to supply chain shifts, digital adoption, and ...

This episode of Pharma Pulse covers new research showing Medicaid cuts could widen pediatric coverage gaps, clinical trial ...

Through its “BMS Patient Connect” platform, the company is lowering out-of-pocket costs and providing nationwide shipping, ...

Ullrich Mayeski, community engagement director of health with GS1 US, emphasizes the critical need to address interoperability challenges at the dispenser level, ranging from small independent ...

This episode of Pharma Pulse covers the CDC’s unanimous vote to broaden COVID-19 vaccine recommendations for all adults, new ...

Ullrich Mayeski, community engagement director of health with GS1 US, outlines how manufacturers, distributors, and dispensers can strengthen end-to-end traceability.

The Generation Park site will create over 600 permanent jobs, support advanced small molecule production, and play a role in ...

Ullrich Mayeski, community engagement director of health with GS1 US, explains how with over a decade of collaboration, ...

The South Korean pharma company’s US subsidiary is purchasing Eli Lilly’s Branchburg, NJ site to safeguard against potential ...

This episode of Pharma Pulse covers ACIP’s move toward shared decision-making for COVID-19 vaccines, Pfizer’s acquisition of ...

Ullrich Mayeski, community engagement director of health with GS1 US, describes of the organization’s EPCIS standard for meeting DSCSA requirements while underscoring that true supply chain success ...